{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:47:51Z","timestamp":1792547271544,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1K23HL159313"],"award-info":[{"award-number":["1K23HL159313"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.molmed.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T09:19:19Z","timestamp":1679044759000},"page":"406-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Updates and advances in pyruvate kinase deficiency"],"prefix":"10.1016","volume":"29","author":[{"given":"Neeti","family":"Luke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Al-Samkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-0449","authenticated-orcid":false,"given":"Rachael F.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2023.02.005_bb0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.25753","article-title":"Genotype\u2013phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency","volume":"95","author":"Bianchi","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0010","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.2019000945","article-title":"Management of pyruvate kinase deficiency in children and adults","volume":"136","author":"Grace","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0015","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.24088","article-title":"Erythrocyte pyruvate kinase deficiency: 2015 status report","volume":"90","author":"Grace","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0020","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/BF02758302","article-title":"Red cell pyruvate kinase deficiency in neonatal jaundice cases in India","volume":"73","author":"Kedar","year":"2006","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.molmed.2023.02.005_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000474982","article-title":"Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes","volume":"48","author":"Lakomek","year":"1994","journal-title":"Enzyme Protein"},{"key":"10.1016\/j.molmed.2023.02.005_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7326\/0003-4819-74-1-44","article-title":"The role of the left-shifted or right-shifted oxygen-hemoglobin equilibrium curve","volume":"74","author":"Oski","year":"1971","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.molmed.2023.02.005_bb0035","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood.V98.10.3113","article-title":"Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia","volume":"98","author":"Wang","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0040","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/blood-2016-11-753525","article-title":"AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency","volume":"130","author":"Kung","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bcmd.2015.12.009","article-title":"Red blood cell PK deficiency: an update of PK-LR gene mutation database","volume":"57","author":"Canu","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.molmed.2023.02.005_bb0050","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1182\/blood-2013-09-526087","article-title":"Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression","volume":"123","author":"Viprakasit","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2141.2001.02711.x","article-title":"Molecular characterization of the PK-LR gene in sixteen pyruvate kinase-deficient patients","volume":"113","author":"Zanella","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.blre.2007.01.001","article-title":"Pyruvate kinase deficiency: the genotype-phenotype association","volume":"21","author":"Zanella","year":"2007","journal-title":"Blood Rev."},{"key":"10.1016\/j.molmed.2023.02.005_bb0065","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2017-10-810796","article-title":"Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study","volume":"131","author":"Grace","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0070","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1182\/blood.V95.11.3585","article-title":"Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population","volume":"95","author":"Beutler","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0075","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood.V96.12.4005","article-title":"Prevalence of pyruvate kinase deficiency in northern European population in the north of England. Northern Region Haematologists Group","volume":"96","author":"Carey","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/adc.44.235.373","article-title":"Screening of pyruvate kinase deficiency and G6PD deficiency in Chinese newborn in Hong Kong","volume":"44","author":"Fung","year":"1969","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.molmed.2023.02.005_bb0085","first-page":"1","article-title":"Pyruvate kinase deficient hemolytic anemia in an Amish isolate","volume":"17","author":"Bowman","year":"1965","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2023.02.005_bb0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ajh.22118","article-title":"Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: longitudinal risk and disease management","volume":"86","author":"Rider","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0095","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V83.10.2817.2817","article-title":"Mutations in the pyruvate kinase L gene in patients with hereditary hemolytic anemia","volume":"83","author":"Lenzner","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0100","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0002-9343(87)90648-6","article-title":"Elevated pyruvate kinase activity in patients with hemolytic anemia due to red cell pyruvate kinase \"deficiency\"","volume":"83","author":"Beutler","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.molmed.2023.02.005_bb0105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/pbc.21720","article-title":"Relative red blood cell enzyme levels as a clue to the diagnosis of pyruvate kinase deficiency","volume":"51","author":"Titapiwatanakun","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.molmed.2023.02.005_bb0110","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/bjh.16724","article-title":"The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency","volume":"192","author":"Al-Samkari","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2005.05527.x","article-title":"Red cell pyruvate kinase deficiency: molecular and clinical aspects","volume":"130","author":"Zanella","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0120","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1055\/s-2008-1055521","article-title":"Diagnosis of pyruvate kinase deficiency in the presence of an elevated reticulocyte count","volume":"120","author":"Pekrun","year":"1995","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.molmed.2023.02.005_bb0125","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1073\/pnas.90.9.4324","article-title":"Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia","volume":"90","author":"Baronciani","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2023.02.005_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ajh.25325","article-title":"Addressing the diagnostic gaps in pyruvate kinase deficiency: consensus recommendations on the diagnosis of pyruvate kinase deficiency","volume":"94","author":"Bianchi","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/ijlh.12610","article-title":"Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene","volume":"39","author":"Jaouani","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0140","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood.V84.7.2354.2354","article-title":"Prenatal diagnosis of pyruvate kinase deficiency","volume":"84","author":"Baronciani","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/adc.69.5_Spec_No.523","article-title":"Fetal anaemia due to pyruvate kinase deficiency","volume":"69","author":"Gilsanz","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.molmed.2023.02.005_bb0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004310051314","article-title":"Hydrops fetalis associated with erythrocyte pyruvate kinase deficiency","volume":"159","author":"Ferreira","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.molmed.2023.02.005_bb0155","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/bloodadvances.2021004675","article-title":"Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency","volume":"6","author":"Al-Samkari","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.molmed.2023.02.005_bb0160","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1471-0528.2002.01083.x","article-title":"Pyruvate kinase deficiency in pregnancy complicated by iron overload","volume":"109","author":"Dolan","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.molmed.2023.02.005_bb0165","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1097\/00006250-198003001-00013","article-title":"Hemolytic anemia and pyruvate kinase deficiency in pregnancy","volume":"55","author":"Amankwah","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0170","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3324\/haematol.2019.240846","article-title":"The variable manifestations of disease in pyruvate kinase deficiency and their management","volume":"105","author":"Al-Samkari","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2023.02.005_bb0175","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3324\/haematol.2016.161166","article-title":"Recommendations regarding splenectomy in hereditary hemolytic anemias","volume":"102","author":"Iolascon","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2023.02.005_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2141.1978.tb07128.x","article-title":"Erythrocyte populations in pyruvate kinase deficiency anaemia following splenectomy. II. Cell deformability","volume":"39","author":"Leblond","year":"1978","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0185","first-page":"367","article-title":"Pyruvate kinase deficiency","volume":"8","author":"Tanaka","year":"1971","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM196801112780203","article-title":"Life-span and organ sequestration of the red cells in pyruvate kinase deficiency","volume":"278","author":"Nathan","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2023.02.005_bb0195","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2003.04208_2.x","article-title":"The dangers of iron overload in pyruvate kinase deficiency","volume":"120","author":"Marshall","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29148","article-title":"Pyruvate kinase deficiency in children","volume":"68","author":"Chonat","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.molmed.2023.02.005_bb0205","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.3324\/haematol.2018.196295","article-title":"Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study","volume":"104","author":"van Beers","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2023.02.005_bb0210","first-page":"E281","article-title":"Characterization of the severe phenotype of pyruvate kinase deficiency","author":"Al-Samkari","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0215","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ejh.13572","article-title":"Comorbidities and complications in adults with pyruvate kinase deficiency","volume":"106","author":"Boscoe","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2020-136598","article-title":"Early-onset osteopenia and osteoporosis in patients with pyruvate kinase deficiency","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0225","article-title":"Paravertebral extramedullary hematopoiesis due to pyruvate kinase deficiency","volume":"90","author":"Plensa","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2023.02.005_bb0230","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1212\/WNL.29.4.510","article-title":"Spinal cord compression by extramedullary hemopoietic tissue in pyruvate-kinase-deficiency-caused hemolytic anemia","volume":"29","author":"Rutgers","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2023.02.005_bb0235","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajh.10380","article-title":"Ineffective erythropoiesis in the spleen of a patient with pyruvate kinase deficiency","volume":"74","author":"Aizawa","year":"2003","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0240","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211066070","article-title":"Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias","volume":"12","author":"Al-Samkari","year":"2021","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/cpdd.604","article-title":"Phase 1 single- and multiple-ascending-dose randomized studies of the safety, pharmacokinetics, and pharmacodynamics of AG-348, a first-in-class allosteric activator of pyruvate kinase R, in healthy volunteers","volume":"8","author":"Yang","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.molmed.2023.02.005_bb0250","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1902678","article-title":"Safety and efficacy of mitapivat in pyruvate kinase deficiency","volume":"381","author":"Grace","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2023.02.005_bb0255","series-title":"Proceedings of the European Haematology Association (EHA) Virtual Congress","first-page":"17","article-title":"ACTIVATE: a phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with pyruvate kinase deficiency who are not regularly transfused","author":"Al-Samkari","year":"2021"},{"key":"10.1016\/j.molmed.2023.02.005_bb0260","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa2116634","article-title":"Mitapivat versus placebo for pyruvate kinase deficiency","volume":"386","author":"Al-Samkari","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2023.02.005_bb0265","series-title":"Proceedings of the European Hematology Association","first-page":"1429","article-title":"Long-term treatment with oral mitapivat is associated with normalization of hemoglobin levels in patients with pyruvate kinase deficiency","author":"Barcellini","year":"2022"},{"key":"10.1016\/j.molmed.2023.02.005_bb0270","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood-2022-168954","article-title":"Long-term improvements in patient-reported outcomes in patients with pyruvate kinase deficiency treated with mitapivat","volume":"140","author":"Kuo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0275","series-title":"Proceedings of the European Haematology Association (EHA) Virtual Congress","first-page":"17","article-title":"ACTIVATE-T: a phase 3, open-label, multicenter study of mitapivat in adults with pyruvate kinase deficiency who are regularly transfused","author":"Glenth\u00f8j","year":"2021"},{"key":"10.1016\/j.molmed.2023.02.005_bb0280","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1182\/blood.2020008635","article-title":"Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy","volume":"137","author":"Rab","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0285","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood.2022015403","article-title":"A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease","volume":"140","author":"Xu","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0290","doi-asserted-by":"crossref","first-page":"E226","DOI":"10.1002\/ajh.26554","article-title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: a phase 2, open-label study","volume":"97","author":"van Dijk","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molmed.2023.02.005_bb0295","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/jpet.121.000743","article-title":"Etavopivat, a pyruvate kinase activator in red blood cells, for the treatment of sickle cell disease","volume":"380","author":"Schroeder","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.molmed.2023.02.005_bb0300","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(22)01337-X","article-title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent alpha-thalassaemia or beta-thalassaemia: an open-label, multicentre, phase 2 study","volume":"400","author":"Kuo","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2023.02.005_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2020-142232","article-title":"The pyruvate kinase activator mitapivat ameliorates anemia and prevents iron overload in a mouse model of hereditary spherocytosis","volume":"136","author":"Matt\u00e8","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0310","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1182\/blood-2022-157719","article-title":"Results from the single and multiple ascending dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AG-946 in healthy volunteers","volume":"140","author":"Dai Gurov","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0315","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2021-145374","article-title":"Pharmacodynamic effects of AG-946, a highly potent next-generation activator of pyruvate kinase, in ex vivo treatment of red blood cells from sickle cell disease patients","volume":"138","author":"Rab","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0320","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1182\/blood-2022-168907","article-title":"A Phase 2a\/2b multicenter study of AG-946 in patients with anemia due to lower-risk myelodysplastic syndromes","volume":"140","author":"Al-Samkari","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0325","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/bmt.2016.218","article-title":"Hemolytic anemia with null PKLR mutations identified using whole exome sequencing and cured by hematopoietic stem cell transplantation combined with splenectomy","volume":"51","author":"Kim","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.molmed.2023.02.005_bb0330","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1702576","article-title":"Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency","volume":"26","author":"Tanphaichitr","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.molmed.2023.02.005_bb0335","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.3324\/haematol.2017.177857","article-title":"Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency","volume":"103","author":"van Straaten","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2023.02.005_bb0340","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.02.005_bb0345","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/mt.2009.200","article-title":"Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme","volume":"17","author":"Meza","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2023.02.005_bb0350","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1182\/blood-2003-10-3705","article-title":"Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency","volume":"103","author":"Richard","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0355","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.V83.8.2305.2305","article-title":"Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: implications for gene therapy of human PK deficiency","volume":"83","author":"Tani","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.02.005_bb0360","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2022-170948","article-title":"Lentiviral-mediated gene therapy for adults and children with severe pyruvate kinase deficiency: results from a global Phase 1 study","volume":"140","author":"Shah","year":"2022","journal-title":"Blood"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:27:02Z","timestamp":1761463622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491423000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1471491423000370"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2023.02.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates and advances in pyruvate kinase deficiency","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}